Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Nanexa AB (publ)
  6. News
  7. Summary
    NANEXA   SE0007074166

NANEXA AB (PUBL)

(NANEXA)
  Report
Delayed Quote. Delayed Nasdaq Stockholm - 10/15 11:29:50 am
3.9 SEK   -4.41%
10/13NANEXA : signs additional evaluation agreement
AQ
10/05NANEXA : receives decision on sanction fee from Finansinspektionen regarding case from 2017
AQ
09/24NANEXA : pauses NEX-18 study
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Nanexa AB Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2021

08/20/2021 | 02:00am EDT

Nanexa AB Announced Earnings Results for the second quarter and six months ended June 30, 2021. For the quarter, the company reported net sales of SEK 5,121,000 against SEK 4,993,000 a year ago. Total operating revenue was SEK 5,121,000 against SEK 4,993,000 a year ago. Operating loss (LBIT) was SEK 8,296,000 against SEK 6,430,000 a year ago. Loss for the period was SEK 8,339,000 against SEK 6,494,000 a year ago. Loss per share was SEK 0.33 against SEK 0.31 a year ago. For the six months, the company reported net sales of SEK 878,000 against SEK 1,289,000 a year ago. Total operating revenue was SEK 10,173,000 against SEK 8,831,000 a year ago. Operating loss (LBIT) was SEK 14,919,000 against SEK 9,899,000 a year ago. Loss for the period was SEK 6,494,000 against SEK 15,008,000 a year ago. Loss per share was SEK 0.64 against SEK 0.54 a year ago.


ę S&P Capital IQ 2021
All news about NANEXA AB (PUBL)
10/13NANEXA : signs additional evaluation agreement
AQ
10/05NANEXA : receives decision on sanction fee from Finansinspektionen regarding case from 201..
AQ
09/24NANEXA : pauses NEX-18 study
AQ
09/24Nanexa Announces Inclusion of Patients in its Phase I Study with NEX-18
CI
09/03NANEXA : receives orders for coating of sensors
AQ
09/03Nanexa Receives Orders for Coating of Sensors
CI
08/20NANEXA : publishes interim report for January – June 2021
AQ
08/20Nanexa AB Announces Earnings Results for the Second Quarter and Six Months Ended June 3..
CI
07/07NANEXA : EPO communicates intention to grant Nanexa's PharmaShell« patent in Europe
AQ
07/07Nanexa AB Provides Updates on its Patent Grant
CI
More news
Financials
Sales 2021 23,0 M 2,67 M 2,67 M
Net income 2021 -29,0 M -3,37 M -3,37 M
Net cash 2021 112 M 13,0 M 13,0 M
P/E ratio 2021 -6,84x
Yield 2021 -
Capitalization 198 M 23,0 M 23,0 M
EV / Sales 2021 3,73x
EV / Sales 2022 4,87x
Nbr of Employees 13
Free-Float 81,8%
Chart NANEXA AB (PUBL)
Duration : Period :
Nanexa AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 3,90 SEK
Average target price 7,00 SEK
Spread / Average Target 79,5%
EPS Revisions
Managers and Directors
David Westberg Chief Executive Officer
Bj÷rn Wilhelm Svanstr÷m Chief Financial Officer
G÷ran Albert Torstensson Ando Chairman
Magnus Westgren Independent Director
Bengt Arne Gustavsson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
NANEXA AB (PUBL)-64.65%23
ABBOTT LABORATORIES7.31%208 288
MEDTRONIC PLC9.06%171 927
STRYKER CORPORATION8.68%100 428
BECTON, DICKINSON AND COMPANY-3.62%69 259
HOYA CORPORATION20.71%55 655